Clinical trial on common cold

A clinical evaluation of karai rasayanam a siddha drug for Neerkanamantham in children -an open clinical study.

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2016/03/006756

Enrollment

Registered

2016-03-21

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Cold Cough Fever

Interventions

Intervention1: Karai Rasayanam: Oral administration 4ml b.d. for 7 days Control Intervention1: Nil: Nil

Eligibility

Inclusion criteria

Inclusion criteria: cough Running nose Fever History of diarrhea/Flatulence Malaise/headache

Exclusion criteria

Exclusion criteria: Continous fever for more than five days Signs of dehydration Breathing difficulties

Design outcomes

Primary

Measure	Time frame
Good â?? Relieved of all clinical symptoms Moderate â?? Reduction of some clinical symptoms Poor â?? No improvement or change in the clinical symptoms. Timepoint: after 7 days	—

Secondary

Measure	Time frame
Efficacy of the drug Adverse effect of the drug if anyTimepoint: after 14 days	—

Countries

India

Contacts

Public ContactDrMMeenatchi sundaram

National institute of siddha

kalyas53@gmail.com9444946270

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026